Gabriel Lopez MD

Dr. Gabriel Lopez-Berestein is a professor in the Department of Experimental Therapeutics at The University of Texas MD Anderson Cancer Center. Dr. Lopez-Berestein has been with MD Anderson since 1979 and has more than 30 years of experience in cancer research. He has published more than 200 research articles, reviews and book chapters, and has edited books in the area of cancer research. His two major areas of interest are nanoparticulate carriers for the delivery of nucleotides and small molecules in the treatment of cancer, and cell differentiation and apoptosis signaling in acute promyelocytic leukemia (APL).